Radiotherapy Market Size is Projected to Grow at 4.7% CAGR by 2025

1. Radiotherapy Market Size is Projected to Grow at 4.7% CAGR by 2025 In the past decade, radiotherapy equipment and devices have undergone a series of technical advances, helping them being more effective while also being easy to use and cost effective. Market Research Future (MRFR) confirms that the radiotherapy market will record a moderate CAGR of 4.7% by 2025. The latest radiotherapy tools today deliver precise and enhanced radiation dose that fosters the efficiency when it comes to targeting the tumors. The shift from 2D to 3D conformal radiotherapy that enables real-time imaging allows significant radiation conformity to the target as well as dose escalation with higher tumor control. As a result, the market demand has been escalating across the world, as technological innovations continue to trend and medical facilities like hospitals and clinics emerge as prominent end-users. Alarming spike in cancer cases among children has raised the demand for radiotherapy, since this type of therapy is associated with lower side effects compared to chemotherapy. In view of this factor, MRFR experts assume that the market growth is expected to grow at a fantastic rate in the years to come. The International Union against Cancer revealed that in 2017, nearly 160,000 children had cancer while the deadly disease claimed close to 90,000 lives that year. This continuous growth in cancer cases among children is leading to higher demand for radiotherapy and will translate into robust market expansion in subsequent years. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1526 Market Segmentation Radiotherapy industry has been considered for type, application, and end-user. Different radiotherapy types in the market are external beam radiation therapy, systemic radiation therapy and internal radiation therapy. Major applications of radiotherapy include spine cancer, head and neck cancer, skin and lip cancer, prostate cancer, breast cancer, lung cancer, cervical cancer, and others. The equipment used during radiotherapy are radiation therapy simulators, treatment planning systems and linear accelerators. Prominent end-users in the radiotherapy industry are independent radiotherapy centers as well as hospitals.

2. Regional Status Europe, APAC or Asia Pacific, MEA or Middle East & Africa and Americas are the top markets for radiotherapy worldwide. The American market for has been making tremendous progress and has secured the lead backed by the high per capita healthcare spending along with the tendency to adopt the latest technologies in the healthcare sector. Dramatic increase in the cases of cancer across Canada and the US also favors the regional market. Additionally, the rising spending on research activities to improve the effectiveness of radiation therapy techniques including the development of the intensity-modulated and image-guided radiotherapy has landed America at the top of the global market. Flourishing healthcare system and the rising number of radiotherapy centers and hospitals adopting modern technologies has helped Europe secure the second lead in the global market. Significant level of awareness as well as spending on healthcare, rising cases of various types of cancer, and availability of health insurances also fortify the market value in the region. Technological innovations in radiotherapy, like IGRT, 3-DCRT and IMRT in the region have also been favorable. Meanwhile, emergence of new techniques, including stereotactic body radiation therapy has resulted in higher possibility of successful clinical results, thereby fostering the market growth in the region. The APAC market for radiotherapy will note the fastest advancement in the next couple of years, as the government is actively working on fostering the awareness level among people about the available treatment options. Rampant demand for more effective therapies, paired with the mounting burden of cancer in the region raises the need for radiotherapy. Companies in the region are focused on making strategic movies like distribution agreements, product launches and partnerships to elevate their market rankings. Affluent Contenders Some of the most affluent companies in the global market for radiotherapy include Mevion Medical Systems, Inc., Hitachi, Ltd., IBA (Ion Beam Applications Sa), C. R. Bard, Inc., Panacea Medical Technologies Pvt. Ltd., Varian Medical Systems, Inc., P-Cure Ltd., Isoray Medical, Inc., Elekta AB (pub), Optivus Proton Therapy, Inc., Provision Healthcare, LLC, to mention a few. Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/radiotherapy-market-1526 Latest Updates March 2021

3. Science and Technology Facilities Council’s Daresbury Laboratory has boosted its capacity to now include testing of a higher number of new radiotherapy technologies. The facility will now be used for a higher number of testing and production of the linear accelerator technology, which enables delivery of extensively targeted radiation doses for the treatment of a variety of cancers such as prostate, lung, brain, breast, liver, spine, bone, pancreas, and more. Browse Related Reports at: https://www.marketresearchfuture.com/reports/pharmaceutical-robots-market-6531 https://www.marketresearchfuture.com/reports/mitral-valve-stenosis-market-6560 https://www.marketresearchfuture.com/reports/neuroblastoma-market-6555 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 646 845 9312 Email: sales@marketresearchfuture.com